http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20091691-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef4f341fe4f2caf061611a818576e40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2009-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa0be88c51701a9cbe0ad0829b49d426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_092ecf410d9c35eb023bf7c30dda908f
publicationDate 2009-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20091691-A1
titleOfInvention INHALATION FORMULATION INCLUDING ACLIDINIUM
abstract REFERRING TO A PHARMACEUTICAL COMPOSITION FOR INHALATION INCLUDING ACLIDINIUM IN THE FORM OF A DRY POWDER OF A PHARMACEUTICALLY ACCEPTABLE SALT AND A VEHICLE SUCH AS LACTOSE PARTICLES, WHERE THE RATIO IN WEIGHT OF THE ACLIDINIUM WITH RESPECT TO THE VEHICLE IS 1:50 TO 150. THE COMPOSITION MAY CONTAIN ONE OR MORE ACTIVE AGENTS SUCH AS FORMOTEROL FUMARATE, MOMETHASONE FUROATE, SALMETEROL, BUDESONIDE, AMONG OTHERS. SUCH COMPOSITION IS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES, PARTICULARLY, ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
priorityDate 2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11434515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447947087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497181

Total number of triples: 41.